CYP2D6 and breast carcinoma: Patients with breast cancer who are ultrarapid CYP2D6 metabolizers are usually recommended to use a standard dose of tamoxifen.11 However, ultrarapid CYP2D6 metabolizers cannot benefit from tamoxifen if they do not take it.